225 related articles for article (PubMed ID: 25696850)
21. Disruption of follicular dendritic cells-follicular lymphoma cross-talk by the pan-PI3K inhibitor BKM120 (Buparlisib).
Matas-Céspedes A; Rodriguez V; Kalko SG; Vidal-Crespo A; Rosich L; Casserras T; Balsas P; Villamor N; Giné E; Campo E; Roué G; López-Guillermo A; Colomer D; Pérez-Galán P
Clin Cancer Res; 2014 Jul; 20(13):3458-71. PubMed ID: 24799524
[TBL] [Abstract][Full Text] [Related]
22. Microarray studies of prognostic stratification and transformation of follicular lymphomas.
Sigal S; Ninette A; Rechavi G
Best Pract Res Clin Haematol; 2005 Mar; 18(1):143-56. PubMed ID: 15694190
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of cytokines, chemokines and their receptors in follicular lymphoma and reactive follicular hyperplasia: assessment by complementary DNA microarray.
Fujii A; Oshima K; Hamasaki M; Utsunomiya H; Okazaki M; Kagami Y; Seto M; Kikuchi M
Oncol Rep; 2005 May; 13(5):819-24. PubMed ID: 15809744
[TBL] [Abstract][Full Text] [Related]
24. Predicting transformation in follicular lymphoma.
de Jong D; de Boer JP
Leuk Lymphoma; 2009 Sep; 50(9):1406-11. PubMed ID: 19606378
[TBL] [Abstract][Full Text] [Related]
25. Novel acquisitions on biology and management of transformed follicular lymphoma.
Minoia C; Zucca E; Conconi A
Hematol Oncol; 2018 Oct; 36(4):617-623. PubMed ID: 29602222
[TBL] [Abstract][Full Text] [Related]
26. Vulnerabilities in the tumor and microenvironment in follicular lymphoma.
Araujo-Ayala F; Pérez-Galán P; Campo E
Hematol Oncol; 2021 Jun; 39 Suppl 1():83-87. PubMed ID: 34105816
[TBL] [Abstract][Full Text] [Related]
27. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma.
Rossi D; Berra E; Cerri M; Deambrogi C; Barbieri C; Franceschetti S; Lunghi M; Conconi A; Paulli M; Matolcsy A; Pasqualucci L; Capello D; Gaidano G
Haematologica; 2006 Oct; 91(10):1405-9. PubMed ID: 17018394
[TBL] [Abstract][Full Text] [Related]
28. Prognosis of follicular lymphomas.
Luminari S; Federico M
Hematol Oncol; 2006 Jun; 24(2):64-72. PubMed ID: 16514592
[TBL] [Abstract][Full Text] [Related]
29. Premalignant cell dynamics in indolent B-cell malignancies.
Milpied P; Nadel B; Roulland S
Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
[TBL] [Abstract][Full Text] [Related]
30. Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma.
Brodtkorb M; Lingjærde OC; Huse K; Trøen G; Hystad M; Hilden VI; Myklebust JH; Leich E; Rosenwald A; Delabie J; Holte H; Smeland EB
Blood; 2014 Feb; 123(7):1051-4. PubMed ID: 24357726
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of secondary cytogenetic alterations in follicular lymphomas.
Johnson NA; Al-Tourah A; Brown CJ; Connors JM; Gascoyne RD; Horsman DE
Genes Chromosomes Cancer; 2008 Dec; 47(12):1038-48. PubMed ID: 18720523
[TBL] [Abstract][Full Text] [Related]
32. Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review.
Hayslip J; Montero A
Mol Cancer; 2006 Oct; 5():44. PubMed ID: 17026765
[TBL] [Abstract][Full Text] [Related]
33. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
Richendollar BG; Pohlman B; Elson P; Hsi ED
Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
[TBL] [Abstract][Full Text] [Related]
34. Sequential development of histiocytic sarcoma and diffuse large b-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: a divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual.
Wang E; Papalas J; Hutchinson CB; Kulbacki E; Huang Q; Sebastian S; Rehder C; Silbermins D; Moore J; Datto M
Am J Surg Pathol; 2011 Mar; 35(3):457-63. PubMed ID: 21317718
[TBL] [Abstract][Full Text] [Related]
35. Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints.
Andor N; Simonds EF; Czerwinski DK; Chen J; Grimes SM; Wood-Bouwens C; Zheng GXY; Kubit MA; Greer S; Weiss WA; Levy R; Ji HP
Blood; 2019 Mar; 133(10):1119-1129. PubMed ID: 30591526
[TBL] [Abstract][Full Text] [Related]
36. Gene-expression profiling during curcumin-induced apoptosis reveals downregulation of CXCR4.
Skommer J; Wlodkowic D; Pelkonen J
Exp Hematol; 2007 Jan; 35(1):84-95. PubMed ID: 17198877
[TBL] [Abstract][Full Text] [Related]
37. Follicular lymphoma microenvironment: insights provided by single-cell analysis.
Abe Y
J Clin Exp Hematop; 2023 Sep; 63(3):143-151. PubMed ID: 37635086
[TBL] [Abstract][Full Text] [Related]
38. Predicting outcome in follicular lymphoma by using interactive gene pairs.
LeBrun D; Baetz T; Foster C; Farmer P; Sidhu R; Guo H; Harrison K; Somogyi R; Greller LD; Feilotter H
Clin Cancer Res; 2008 Jan; 14(2):478-87. PubMed ID: 18223222
[TBL] [Abstract][Full Text] [Related]
39. Duodenal follicular lymphoma: comprehensive gene expression analysis with insights into pathogenesis.
Takata K; Tanino M; Ennishi D; Tari A; Sato Y; Okada H; Maeda Y; Goto N; Araki H; Harada M; Ando M; Iwamuro M; Tanimoto M; Yamamoto K; Gascoyne RD; Yoshino T
Cancer Sci; 2014 May; 105(5):608-15. PubMed ID: 24602001
[TBL] [Abstract][Full Text] [Related]
40. Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments.
Krull JE; Wenzl K; Hopper MA; Manske MK; Sarangi V; Maurer MJ; Larson MC; Mondello P; Yang Z; Novak JP; Serres M; Whitaker KR; Villasboas Bisneto JC; Habermann TM; Witzig TE; Link BK; Rimsza LM; King RL; Ansell SM; Cerhan JR; Novak AJ
Cell Rep Med; 2024 Mar; 5(3):101443. PubMed ID: 38428430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
